Pain relieving micro-emulsion pharmaceutical composition gel ointment and preparation method thereof
A technology of gel ointment and composition, applied in the field of microemulsion pharmaceutical composition gel ointment and its preparation, to achieve the effect of enhancing stability and improving compatibility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
experiment example 1
[0074] Experimental Example 1: Research on the prescription of microemulsion pharmaceutical composition gel ointment
[0075] One, in the microemulsion pharmaceutical composition gel ointment of the present invention, the influence of gel ointment matrix on microemulsion
[0076] Gel paste base: NP-700, aluminum hydroxide, tartaric acid, aluminum trichloride, aluminum glycolate, EDTA-Na 2 ; Among them, NP-700 is a polymer of 50% polyacrylic acid and 50% sodium polyacrylate, which has good water solubility.
[0077] First, after preparing the microemulsion of the pharmaceutical composition according to the method described in Example 1, add the matrix of the above-mentioned gel ointment respectively, place it on a magnetic stirrer, stir it evenly, and place it for a period of time for observation. The results are shown in Table 1.
[0078] The impact of table 1 gel ointment matrix on microemulsion
[0079]
[0080] As can be seen from the table, after the microemulsion is...
experiment example 2
[0157] Experimental Example 2: Research on transdermal absorption of three forms of pharmaceutical composition gel ointment
[0158] One, the preparation of three forms of pharmaceutical composition gel ointment
[0159] 1. The original pharmaceutical composition gel ointment prescription of the prior art:
[0160] Phase A: NP-700 2g, aluminum glycolate 0.08g, glycerin 12g, PVPP 0.30g
[0161] Phase B: 0.08g tartaric acid, EDTA-Na 2 0.02g, water 4mL
[0162] Phase C: Chuanbai Percolation Solution (4g·mL -1 ), Zanthoxylum bungeanum extract (4g·mL -1 ) each 1mL
[0163] Phase D: borneol 0.25g, mixed volatile oil 0.50mL, absolute ethanol 2mL
[0164] Preparation method: Stir A (NP700, glycerol, aluminum glycerol) and ultrasonically degas, add D (borneol, volatile oil) phase to A phase and stir well. Mix phase C (Chuanxiong Baizhi thick extract, Zanthoxylum Asarum thick extract) evenly, add phases A and D, stir evenly, and ultrasonically remove air bubbles. B (tartaric ac...
experiment example 3
[0269] Experimental example 3: microemulsion gel ointment of the present invention and prior art ointment efficacy comparison
[0270] Analgesic effect on mice
[0271] 1. Experimental materials
[0272] ICR mouse (20 ± 10g), Beijing Weitong Lihua Experimental Animal Technology Co., Ltd. (permit number: SCXK (Beijing) 2006-0009); Microemulsion gel ointment of the present invention (prepared according to Example 1), strong Bone Musk Analgesic Ointment (Henan Lingrui Pharmaceutical Co., Ltd., batch number: 100623), medical adhesive plaster (Beijing Lingrui Sanitary Materials Co., Ltd., batch number: 20100929).
[0273] 2. Methods and results
[0274] (1) Effect on pain threshold of mice induced by hot plate
[0275] The mice were randomly divided into five groups, a positive control group, a blank matrix group, a microemulsion gel ointment group of the present invention, a strong bone musk analgesic ointment, and a medical adhesive plaster group. First, put 60 mice on a hot ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com